Exactech reported its second quarter and first half of 2017 financial results.
Here are second quarter highlights:
1. The company saw a 2 percent jump in second quarter revenue, from $66.1 million in the second quarter of 2016 to $67.3 million.
2. Exactech reported domestic revenue increased to $45.7 million in the second quarter of 2017, compared to the same period the year prior.
3. The company's diluted earnings per share were $0.33 based on $4.8 million net income in the second quarter of 2017.
4. The extremities segment revenue hit $29.5 million in the second quarter of 2017, reflecting a 19 percent increase from the same period in 2016.
5. Knee segment revenue proved flat at $19.6 million in the second quarter of 2017.
6. Exactech's hip segment revenue fell 8 percent to $11.5 million, compared to the second quarter of 2016.
7. The company's 'other' segment, inclusive of biologics and spine, decreased 27 percent to $6.7 million, compared to the second quarter of 2016.
Here are first half of 2017 highlights:
8. In the first half of 2017, Exactech reported $136.8 million in revenue, a 4 percent increase over the same period in 2016.
9. Net income rose 7 percent to $9.4 million in the first half of 2017, compared to the same period the year prior.
10. Extremities segment revenue jumped to $59.4 million, a 20 percent increase over the same period the year prior.
11. Knee segment revenue increased 1 percent over the first half of 2016, to $39.7 million.
12. Hip segment revenue fell 1 percent to $23.6 million, compared to the first half of 2016.
13. 'Other' segment revenue, inclusive of biologics and spine, decreased 24 percent to $14.1 million, compared to the same period the year prior.
The company updated its 2017 revenue guidance to between $267 million and $271 million.